Annals of Oncology · 2017 · 206 citations · 17 references
MedicineOncologyPharmacologyBreast OncologyChemotherapyMedical OncologyBreast Cancer OncologyBreast Cancer PharmacotherapyBreast Cancer RecurrenceMalignant NeoplasmsMetastatic Breast CancerMetastatic Cancer ManagementBreast Cancer ChemotherapyMetastatic Breast Cancer TreatmentMetastatic Carcinoma To The BreastPhase Ii InvestigationSecond-line ChemotherapyStudy PhaseTriple-negative Breast Cancer Therapy
17
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Hannah Farmer, Nuala McCabe, Christopher J. Lord et al. · Nature · 2005 · 6.7K citations
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Helen E. Bryant, Niklas Schultz, Huw D. Thomas et al. · Nature · 2005 · 5.2K citations
Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation
Mark E. Robson, Seock‐Ah Im, Elżbieta Senkus et al. · New England Journal of Medicine · 2017 · 3.2K citations · Full text
Medicine, Oncology, Pharmacology +16
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai, Shar-yin N. Huang, Benu Brata Das et al. · Cancer Research · 2012 · 2.2K citations · Full text
Medicine, Oncology, Pharmacology +17